Home > Financial Ratios > SAKAR HEALTHCARE

SAKAR HEALTHCARE
Core EBITDA Growth

    Back to All Ratios
SAKAR HEALTHCARE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SAKAR HEALTHCARE
Please provide your vote to see the results

SAKAR HEALTHCARE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 9.5620.4132.4710.29-

What is the latest Core EBITDA Growth ratio of SAKAR HEALTHCARE ?

The latest Core EBITDA Growth ratio of SAKAR HEALTHCARE is 9.56 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar20249.56
Mar202320.41
Mar202232.47
Mar202110.29
Mar2020-

How is Core EBITDA Growth of SAKAR HEALTHCARE Trending?

Years Core EBITDA Growth % Change
Mar2024 9.56
-53.16
Mar2023 20.41
-37.14
Mar2022 32.47
215.55
Mar2021 10.29
0
Mar2020 0 -

Other Financial Ratios of SAKAR HEALTHCARE


Compare Core EBITDA Growth ratio of peers of SAKAR HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAKAR HEALTHCARE ₹817.6 Cr 4.2% 1.4% 13.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,991.0 Cr -0.1% 1.3% 5% Stock Analytics
DIVIS LABORATORIES ₹175,720.0 Cr -1.7% 0.5% 47.2% Stock Analytics
CIPLA ₹120,133.0 Cr 0.4% -1.5% -1.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹118,994.0 Cr -0.2% 9% 13.3% Stock Analytics
DR REDDYS LABORATORIES ₹105,562.0 Cr 0.5% -5.7% -9.1% Stock Analytics


SAKAR HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAKAR HEALTHCARE

4.2%

1.4%

13.6%

SENSEX

-0.1%

0.2%

2.1%


You may also like the below Video Courses